Mixing Reason 5 O O
vaccines Reason 5 O O
'safe Reason 5 O O
and Reason 5 O O
effective' Reason 5 O O
Combining Reason 5 O O
first Reason 5 O O
and Reason 5 O O
second Reason 5 O O
doses Reason 5 O O
of Reason 5 O O
the Reason 5 O O
COVID-19 Reason 5 O O
vaccines Reason 5 O O
from Reason 5 O O
AstraZeneca Reason 5 O O
and Reason 5 O O
Pfizer Reason 5 O O
is Reason 5 O O
both Reason 5 O O
safe Reason 5 O O
and Reason 5 O O
effective, Reason 5 O O
according Reason 5 O O
to Reason 5 O O
preliminary Reason 5 O O
results Reason 5 O O
from Reason 5 O O
a Reason 5 O O
Spanish Reason 5 O O
study, Reason 5 O O
which Reason 5 O O
could Reason 5 O O
have Reason 5 O O
major Reason 5 O O
implications Reason 5 O O
for Reason 5 O O
global Reason 5 O O
vaccine Reason 5 O O
roll-out. Reason 5 O O
Scientists Reason 5 O O
at Reason 5 O O
the Reason 5 O O
Carlos Reason 5 ScientificAuthority O
III Reason 5 ScientificAuthority O
Health Reason 5 ScientificAuthority O
Institute Reason 5 ScientificAuthority O
in Reason 5 O O
Madrid Reason 5 O O
say Reason 5 O O
that Reason 5 O O
trial Reason 5 O O
participants Reason 5 O O
who Reason 5 O O
received Reason 5 O O
an Reason 5 O O
AstraZeneca Reason 5 O O
vaccine Reason 5 O O
followed Reason 5 O O
by Reason 5 O O
a Reason 5 O O
Pfizer Reason 5 O O
vaccine Reason 5 O O
showed Reason 5 O O
a Reason 5 O O
strong Reason 5 O O
immune Reason 5 O O
response Reason 5 O O
with Reason 5 O O
minimal Reason 5 O O
side Reason 5 O O
effects. Reason 5 O O
The O O O O
trial O O O O
involved O O O O
441 O O O O
participants O O O O
tested O O O O
alongside O O O O
a O O O O
control O O O O
group O O O O
of O O O O
232 O O O O
people O O O O
who O O O O
did O O O O
not O O O O
receive O O O O
a O O O O
second O O O O
dose. O O O O
"The Reason 5 O O
response Reason 5 O O
of Reason 5 O O
the Reason 5 O O
immune Reason 5 O O
system Reason 5 O O
is Reason 5 O O
greatly Reason 5 O O
enhanced Reason 5 O O
after Reason 5 O O
the Reason 5 O O
second Reason 5 O O
dose Reason 5 O O
of Reason 5 O O
the Reason 5 O O
(Pfizer) Reason 5 O O
vaccine, Reason 5 O O
while Reason 5 O O
the Reason 5 O O
adverse Reason 5 O O
effects Reason 5 O O
observed Reason 5 O O
are Reason 5 O O
within Reason 5 O O
what Reason 5 O O
is Reason 5 O O
expected," Reason 5 O O
said Reason 5 O O
authors Reason 5 O O
of Reason 5 O O
the Reason 5 O O
study, Reason 5 O O
which Reason 5 O O
was Reason 5 O O
released Reason 5 O O
on Reason 5 O O
Tuesday. Reason 5 O O
The Reason 4 O O
data Reason 4 O O
is Reason 4 O O
good Reason 4 O O
news Reason 4 O O
for Reason 4 O O
the Reason 4 O O
vaccine Reason 4 O O
effort, Reason 4 O O
as Reason 4 O O
the Reason 4 O O
strategy Reason 4 O O
of Reason 4 O O
mixing Reason 4 O O
treatments Reason 4 O O
would Reason 4 O O
allow Reason 4 O O
for Reason 4 O O
a Reason 4 O O
more Reason 4 O O
flexible Reason 4 O O
and Reason 4 O O
stable Reason 4 O O
roll-out Reason 4 O O
in Reason 4 O O
areas Reason 4 O O
where Reason 4 O O
a Reason 4 O O
specific Reason 4 O O
vaccine Reason 4 O O
is Reason 4 O O
in Reason 4 O O
short Reason 4 O O
supply, Reason 4 O O
or Reason 4 O O
where Reason 4 O O
regulations Reason 4 O O
interrupt Reason 4 O O
distribution. Reason 4 O O
Some Reason 5 O O
experts Reason 5 O O
have Reason 5 O O
also Reason 5 O O
theorized Reason 5 O O
that Reason 5 O O
mixing Reason 5 O O
vaccines Reason 5 O O
might Reason 5 O O
provide Reason 5 O O
greater Reason 5 O O
protection Reason 5 O O
against Reason 5 O O
variants. Reason 5 O O
After Reason 4 O O
reviewing Reason 4 O O
the Reason 4 O O
new Reason 4 O O
data, Reason 4 O O
Spain's Reason 4 ScientificAuthority O
health Reason 4 ScientificAuthority O
department Reason 4 ScientificAuthority O
is Reason 4 O O
set Reason 4 O O
to Reason 4 O O
authorize Reason 4 O O
the Reason 4 O O
use Reason 4 O O
of Reason 4 O O
the Reason 4 O O
Pfizer Reason 4 O O
vaccine Reason 4 O O
as Reason 4 O O
a Reason 4 O O
follow-up Reason 4 O O
shot Reason 4 O O
among Reason 4 O O
1.5 Reason 4 O O
million Reason 4 O O
people Reason 4 O O
under Reason 4 O O
60 Reason 4 O O
years Reason 4 O O
old Reason 4 O O
who Reason 4 O O
have Reason 4 O O
already Reason 4 O O
received Reason 4 O O
the Reason 4 O O
AstraZeneca Reason 4 O O
jab, Reason 4 O O
Spanish Reason 4 O O
paper Reason 4 O O
El Reason 4 O O
Pais Reason 4 O O
reported Reason 4 O O
on Reason 4 O O
Wednesday. Reason 4 O O
Spain Reason 2 O O
had Reason 2 O O
previously Reason 2 O O
suspended Reason 2 O O
use Reason 2 O O
of Reason 2 O O
AstraZeneca Reason 2 O O
in Reason 2 O O
under Reason 2 O O
60s Reason 2 O O
due Reason 2 O O
to Reason 2 O O
a Reason 2 O O
possible Reason 2 O O
association Reason 2 O O
with Reason 2 O O
rare Reason 2 O O
blood Reason 2 O O
clots, Reason 2 O O
leaving Reason 2 O O
more Reason 2 O O
than Reason 2 O O
one Reason 2 O O
million Reason 2 O O
people Reason 2 O O
who Reason 2 O O
had Reason 2 O O
already Reason 2 O O
received Reason 2 O O
one Reason 2 O O
shot Reason 2 O O
questioning Reason 2 O O
whether Reason 2 O O
they Reason 2 O O
would Reason 2 O O
get Reason 2 O O
a Reason 2 O O
full Reason 2 O O
course. Reason 2 O O
Spanish Reason 2 O O
authorities Reason 2 O O
are Reason 2 O O
still Reason 2 O O
considering Reason 2 O O
whether Reason 2 O O
the Reason 2 O O
AstraZeneca Reason 2 O O
restriction Reason 2 O O
should Reason 2 O O
be Reason 2 O O
lifted Reason 2 O O
for Reason 2 O O
those Reason 2 O O
who Reason 2 O O
have Reason 2 O O
already Reason 2 O O
received Reason 2 O O
one Reason 2 O O
dose, Reason 2 O O
according Reason 2 O O
to Reason 2 O O
El Reason 2 O O
Pais. Reason 2 O O
British Reason 3 O O
researchers Reason 3 O O
are Reason 3 O O
also Reason 3 O O
studying Reason 3 O O
whether Reason 3 O O
combinations Reason 3 O O
of Reason 3 O O
COVID-19 Reason 3 O O
vaccines Reason 3 O O
provide Reason 3 O O
sufficient Reason 3 O O
protection. Reason 3 O O
Preliminary O O O O
results O O O O
released O O O O
last O O O O
week O O O O
from O O O O
Oxford O O ScientificAuthority O
University's O O ScientificAuthority O
Com-Cov O O O O
trial O O O O
of O O O O
830 O O O O
volunteers O O O O
indicated O O O O
that O O O O
mixing O O O O
doses O O O O
of O O O O
the O O O O
Pfizer O O O O
and O O O O
AstraZeneca O O O O
vaccine O O O O
led O O O O
to O O O O
an O O O O
increase O O O O
in O O O O
mild O O O O
side O O O O
effects, O O O O
though O O O O
adverse O O O O
reactions O O O O
were O O O O
short-lived, O O O O
and O O O O
there O O O O
were O O O O
no O O O O
other O O O O
safety O O O O
concerns. O O O O
In O O O O
April, O O O O
the O O O O
ongoing O O O O
United O O O O
Kingdom O O O O
trial O O O O
recruited O O O O
1,050 O O O O
more O O O O
volunteers O O O O
and O O O O
expanded O O O O
to O O O O
test O O O O
combinations O O O O
of O O O O
the O O O O
Novavax O O O O
and O O O O
Moderna O O O O
vaccines O O O O
alongside O O O O
the O O O O
AstraZeneca O O O O
and O O O O
Pfizer O O O O
treatments. O O O O
Matthew Reason 5 O O
Snape, Reason 5 O O
who Reason 5 O O
is Reason 5 O O
chief Reason 5 O O
investigator Reason 5 O O
of Reason 5 O O
the Reason 5 O O
UK Reason 5 O O
study, Reason 5 O O
said Reason 5 O O
mixing Reason 5 O O
vaccines Reason 5 O O
could Reason 5 O O
"massively Reason 5 O O
increase Reason 5 O O
the Reason 5 O O
flexibility Reason 5 O O
and Reason 5 O O
resilience Reason 5 O O
of Reason 5 O O
the Reason 5 O O
immunization Reason 5 O O
program". Reason 5 O O
"It Reason 4 O O
will Reason 4 O O
mean Reason 4 O O
we Reason 4 O O
can Reason 4 O O
roll Reason 4 O O
these Reason 4 O O
vaccines Reason 4 O O
out Reason 4 O O
more Reason 4 O O
quickly, Reason 4 O O
not Reason 4 O O
just Reason 4 O O
in Reason 4 O O
the Reason 4 O O
UK Reason 4 O O
but Reason 4 O O
internationally," Reason 4 O O
Snape Reason 4 O O
told Reason 4 O O
the Reason 4 O O
BBC. Reason 4 O O
